Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rong Deng

Showing results (361-370 of 470) with videos related to

Pageof 47
Sort By:
Antimicrobial Agents and Chemotherapy|June 10, 2015
Phase 1 Randomized, Double-Blind, Placebo-Controlled Study of RG7667, an Anticytomegalovirus Combination Monoclonal Antibody Therapy, in Healthy AdultsJulie H Ishida, Tracy Burgess, Michael A Derby, et al.
Molecular Cancer Therapeutics|April 18, 2009
ExcisaninA, a diterpenoid compound purified from Isodon MacrocalyxinD, induces tumor cells apoptosis and suppresses tumor growth through inhibition of PKB/AKT kinase activity and blockade of its signal pathwayRong Deng, Jun Tang, Liang-Ping Xia, et al.
Cell Biology International|October 9, 2007
Rhabdastrellic acid-A inhibited PI3K/Akt pathway and induced apoptosis in human leukemia HL-60 cellsJing-Feng Guo, Jun-Min Zhou, Yong Zhang, et al.
Advanced Materials (Deerfield Beach, Fla.)|June 13, 2024
Accelerating the Rate-Determining Steps of Sulfur Conversion Reaction for Lithium-Sulfur Batteries Working at an Ultrawide Temperature RangeDing-Rong Deng, Hai-Ji Xiong, Yu-Lin Luo, et al.
Journal of Cellular and Molecular Medicine|November 4, 2020
Dynamics of NK, CD8 and Tfh cell mediated the production of cytokines and antiviral antibodies in Chinese patients with moderate COVID-19Lin Yan, Bei Cai, Yi Li, et al.
Mabs|February 27, 2016
Preclinical pharmacokinetics, pharmacodynamics, tissue distribution, and tumor penetration of anti-PD-L1 monoclonal antibody, an immune checkpoint inhibitorRong Deng, Daniela Bumbaca, Cinthia V Pastuskovas, et al.
Antimicrobial Agents and Chemotherapy|June 1, 2017
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study To Investigate the Safety, Tolerability, and Pharmacokinetics of an Anti-Influenza B Virus Monoclonal Antibody, MHAB5553A, in Healthy VolunteersJeremy J Lim, Michael A Derby, Yaping Zhang, et al.
Journal of Clinical Pharmacology|July 5, 2020
Pharmacokinetics of the Monoclonal Antibody MHAA4549A Administered in Combination With Oseltamivir in Patients Hospitalized With Severe Influenza A InfectionRong Deng, Gaohong She, Mauricio Maia, et al.
Molecular Cancer|May 13, 2025
Profiling triple-negative breast cancer-specific super-enhancers identifies high-risk mesenchymal development subtype and BETi-Targetable vulnerabilitiesQing-Shan Chen, Rui-Zhao Cai, Yan Wang, et al.
Journal of Translational Medicine|February 12, 2013
Hirsutanol A, a novel sesquiterpene compound from fungus Chondrostereum sp., induces apoptosis and inhibits tumor growth through mitochondrial-independent ROS production: hirsutanol A inhibits tumor growth through ROS productionFen Yang, Wen-Dan Chen, Rong Deng, et al.
Pageof 47

Showing results (361-370 of 470) with videos related to

Sort By:
Pageof 47
Antimicrobial Agents and Chemotherapy|June 10, 2015
Phase 1 Randomized, Double-Blind, Placebo-Controlled Study of RG7667, an Anticytomegalovirus Combination Monoclonal Antibody Therapy, in Healthy AdultsJulie H Ishida, Tracy Burgess, Michael A Derby, et al.
Molecular Cancer Therapeutics|April 18, 2009
ExcisaninA, a diterpenoid compound purified from Isodon MacrocalyxinD, induces tumor cells apoptosis and suppresses tumor growth through inhibition of PKB/AKT kinase activity and blockade of its signal pathwayRong Deng, Jun Tang, Liang-Ping Xia, et al.
Cell Biology International|October 9, 2007
Rhabdastrellic acid-A inhibited PI3K/Akt pathway and induced apoptosis in human leukemia HL-60 cellsJing-Feng Guo, Jun-Min Zhou, Yong Zhang, et al.
Advanced Materials (Deerfield Beach, Fla.)|June 13, 2024
Accelerating the Rate-Determining Steps of Sulfur Conversion Reaction for Lithium-Sulfur Batteries Working at an Ultrawide Temperature RangeDing-Rong Deng, Hai-Ji Xiong, Yu-Lin Luo, et al.
Journal of Cellular and Molecular Medicine|November 4, 2020
Dynamics of NK, CD8 and Tfh cell mediated the production of cytokines and antiviral antibodies in Chinese patients with moderate COVID-19Lin Yan, Bei Cai, Yi Li, et al.
Mabs|February 27, 2016
Preclinical pharmacokinetics, pharmacodynamics, tissue distribution, and tumor penetration of anti-PD-L1 monoclonal antibody, an immune checkpoint inhibitorRong Deng, Daniela Bumbaca, Cinthia V Pastuskovas, et al.
Antimicrobial Agents and Chemotherapy|June 1, 2017
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study To Investigate the Safety, Tolerability, and Pharmacokinetics of an Anti-Influenza B Virus Monoclonal Antibody, MHAB5553A, in Healthy VolunteersJeremy J Lim, Michael A Derby, Yaping Zhang, et al.
Journal of Clinical Pharmacology|July 5, 2020
Pharmacokinetics of the Monoclonal Antibody MHAA4549A Administered in Combination With Oseltamivir in Patients Hospitalized With Severe Influenza A InfectionRong Deng, Gaohong She, Mauricio Maia, et al.
Molecular Cancer|May 13, 2025
Profiling triple-negative breast cancer-specific super-enhancers identifies high-risk mesenchymal development subtype and BETi-Targetable vulnerabilitiesQing-Shan Chen, Rui-Zhao Cai, Yan Wang, et al.
Journal of Translational Medicine|February 12, 2013
Hirsutanol A, a novel sesquiterpene compound from fungus Chondrostereum sp., induces apoptosis and inhibits tumor growth through mitochondrial-independent ROS production: hirsutanol A inhibits tumor growth through ROS productionFen Yang, Wen-Dan Chen, Rong Deng, et al.
Pageof 47